These results suggest that DKK1 CRD2 is involved in the Wnt canonical pathway, whereas DKK1 CRD1 is involved in the Wnt non-canonical pathway, leading to immune cell activation and tumor cell cytotoxicity. Here, DKK1 is linked to neoplasm.